Revalia Bio Launches ‘Human Data Trials’ with $14.5M to Transform Drug Development
What You Should Know:
– Revalia Bio Inc., a new pre-clinical research company secures $14.5M in seed funding round to support the launch of its “Human Data Trials”.
– The funding was co-led by America’s Frontier…
Continue Reading

